Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Copper Complex as Anti-Tumor Agents

05.09.2012
</a><strong>Background</strong><br>

There is still a considerable demand for the improvement of cytotoxic cancer therapeutics regarding the toxicity and the tolerance. While platinum-based chemotherapy is the standard of care for patients with lung cancer, other metal-containing agents could not be established in the treatment of cancer diseases.<br><br>

<strong>Technology</strong><br> Therefore, we offer a novel copper-based compound, displaying strong and selective anti-tumor activity in a broad range of hematological cancers and solid tumors, high efficiency against relapse, improved tolerance and reduced toxicity.<br><br> In vitro studies revealed strong apoptotic and anti-proliferative effects of metal- organic copper sarcolysin (MOC*Scr) in comparison to other cytotoxic drugs. When combined with other cytotoxic drugs, MOC*Scr showed strong synergistic effects pointing towards a different mechanism. Furthermore, MOC*Scr demonstrated potent activity in cell lines resistant to other standard drugs such as Vincristin, Daunorubicin and Doxorubicin. Additional in vivo studies revealed that the MOC*Src treatment leads to significant tumor growth reduction of 60-90% in syngenic and xenograft tumor models. Also terminal stage IV patients benefited from the treatment with MOC compound in investigator initiated trials.<br><br> Thus, these results position MOC*Scr as an exciting new cancer therapeutic agent.<br><br> <b>Benefits:</b><ul> <li>Excellent anti-tumor activity and synergistic effect with other cytotoxic drugs</li> <li>Wide spectrum of application including solid tumors and hematological cancers</li> <li>Overcomes resistances ex vivo</li> <li>Convenient oral administration</li> <li>Small molecule with short and simple synthesis</li></ul> <p><strong>IP Rights</strong><br> EP and PCT (DE, EP, AU, BR, CA, CN, IN, JP, RU, US) application filed in February 2008 and February 2009 <br><br> <strong>Patent Owner</strong><br> Technology Development Funds of Investitionsbank Berlin

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2735&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.

nachricht Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

The Maturation Pattern of the Hippocampus Drives Human Memory Deve

23.07.2018 | Science Education

FAU researchers identify Parkinson's disease as a possible autoimmune disease

23.07.2018 | Health and Medicine

O2 stable hydrogenases for applications

23.07.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>